What smart money is saying about CareDx, Inc.
CDNA
No fund has written a full thesis on CareDx, Inc. in our archive, but 2 fund letters report a position in it — most recently Baron Discovery Fund in June 2026.
Get an email when a fund writes about it
2
Reported positions
2
Bought
0
Sold
2
Letters
Position history
Every position in CareDx, Inc. on record in the archive was reported in Q2 2026, across 2 fund letters — 2 opened or added to the position.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 2 | 0 | 0 |
Fund activity · 2 positions · 2 moves
- AddedBaron Discovery FundJune 2026
“Shares of CareDx, Inc. contributed to performance. CareDx sells diagnostic testing services which detect early rejection of heart, kidney, and lung transplants. Shares declined dramatically in the third quarter of 2025, as the Centers for Medicare and Medicaid Services (CMS) MolDX Program issued a draft local coverage decision (LCD) that, if finalized, would significantly limit reimbursement for CareDx's tests. In particular, the draft LCD would remove increased coverage for HeartCare (which is a dual test including donor derived cell-free DNA (dd-cfDNA) and gene expression profiling (GEP) despite definitive data showing a heightened clinical benefit from using both tests. The draft LCD also proposes a bundled payment reimbursement model that has been studied and is recommended by medical societies. It is not yet clear whether the structure of the bundling program would help or hurt CareDx’s revenues. We thought that at their lowest levels of $11 to $12 last summer, CareDx shares were pricing in a worst-case scenario, and we meaningfully increased our position at those levels.”
CareDx, Inc. - June 2026
“We thought that at their lowest levels of $11 to $12 last summer, CareDx shares were pricing in a worst-case scenario, and we meaningfully increased our position at those levels.”
CareDx, Inc.
Read the letters behind these CareDx, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger